NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
NERVGEN PHARMA CORP.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.54−0.05 (-3.14%)
Close on Oct 19, 2026
Dividends
Nervgen Pharma has not reported a dividend
No dividend per share appears in Nervgen Pharma's annual filings since fiscal 2023.